Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia approves swine flu vaccine; trials in pregnant women in US

This article was originally published in SRA

Executive Summary

Pharmaceutical companies around the world are making progress in tackling the 2009 H1N1 influenza (swine flu) virus. Australia’s Therapeutic Goods Administration is the latest regulatory authority to grant approval to an H1N1 vaccine1,2. Approval was granted using the so-called progressive assessment process, whereby the TGA analysed data on a rolling basis as they became available.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114603

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel